- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02876926
Evaluating a Real-Time, Remote Monitoring System for Home-Based HIV Testing ((eTEST))
January 17, 2019 updated by: Tyler Wray, Brown University
Exploring Use of a Real-time, Remote Monitoring and Follow-up System for Home-based, HIV Self-testing Among High-risk Men Who Have Sex With Men (MSM)
This study explores whether offering follow-up counseling and referral over the phone after using a home-based HIV test increases rates of ever and repeat testing, compared with home-based testing with no follow-up (HBST alone) or mailing reminders for clinic-based testing.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
65
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Rhode Island
-
Providence, Rhode Island, United States, 02906
- Brown University School of Public Health
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Sex with a partner met online in the past year
- Anal sex (either insertive or receptive) with a casual male partner in the past 6 months without using condoms or pre-exposure prophylaxis
- Own a smartphone (iOS or Android) with a service contract and data plan
- Have a stable address where mail can be received
- Speak English fluently
Exclusion Criteria:
- Having tested for HIV in the last year
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: "Enhanced" home-based testing
These participants will download a study-specific smartphone app ("eTEST"), and receive home-based HIV test kits in the mail every 3 months.
These kits will have been fit with sensors that enable remote detection of when the kit was opened.
Qualified HIV test counselors (QHTC) will then follow up with these participants within 24 hours of receiving notification that the test has been opened to conduct routine counseling, offer referrals for other services, and connect those with reactive results with follow-up care.
|
A standard home-based HIV test kit, fit with a Bluetooth low energy beacon to allow remote monitoring.
|
Active Comparator: Home-based testing alone
These participants will receive a typical home-based test for HIV in the mail every 3 months, but no phone-based follow-up will be provided.
|
A standard home-based HIV test kit.
|
Sham Comparator: Reminders for clinic-based testing
Participants in this condition will receive a letter in the mail every 3 months reminding them to be tested at a local clinic for free.
|
Letters reminding patients to get tested at a free clinic location
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Participants Who Received HIV Testing
Time Frame: Up to 28 weeks
|
Count of the number of participants who reported receiving HIV testing.
|
Up to 28 weeks
|
Number of Participants Who Reported Having Been Referred for Pre-exposure Prophylaxis
Time Frame: Up to 28 weeks
|
Count of the number of participants who reported receiving a referral for pre-exposure prophylaxis from a counselor or medical professional.
|
Up to 28 weeks
|
Number of Participants Who Reported Having Actually Received a Prescription for Pre-exposure Prophylaxis
Time Frame: Up to 28 weeks
|
Count of the number of participants who reported actually having received a prescription for pre-exposure prophylaxis after having been referred by a medical professional.
|
Up to 28 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2016
Primary Completion (Actual)
February 15, 2018
Study Completion (Actual)
February 15, 2018
Study Registration Dates
First Submitted
August 17, 2016
First Submitted That Met QC Criteria
August 19, 2016
First Posted (Estimate)
August 24, 2016
Study Record Updates
Last Update Posted (Actual)
April 19, 2019
Last Update Submitted That Met QC Criteria
January 17, 2019
Last Verified
January 1, 2019
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 1508001315
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HIV
-
University of Alabama at BirminghamMobile County Health Deparment; Alabama Department of Public HealthRecruitingHIV | HIV Testing | HIV Linkage to Care | HIV TreatmentUnited States
-
French National Agency for Research on AIDS and...Elizabeth Glaser Pediatric AIDS FoundationCompletedPartner HIV Testing | Couple HIV Counseling | Couple Communication | HIV IncidenceCameroon, Dominican Republic, Georgia, India
-
ANRS, Emerging Infectious DiseasesHopital Universitaire Robert-Debre; Institut de Recherche pour le Developpement and other collaboratorsUnknownHIV | HIV-uninfected Children | Children Exposed to HIVCameroon
-
University of MinnesotaWithdrawnHIV Infections | HIV/AIDS | Hiv | AIDS | Aids/Hiv Problem | AIDS and InfectionsUnited States
-
CDC FoundationGilead SciencesUnknownHIV Preexposure Prophylaxis | HIV ChemoprophylaxisUnited States
-
Africa Health Research InstituteLondon School of Hygiene and Tropical Medicine; University College, London; University... and other collaboratorsRecruiting
-
Massachusetts General HospitalNational Institute of Mental Health (NIMH); Fenway Community Health; Tuberculosis...CompletedHIV/STI Risk | HIV/STI IncidenceUnited States, India
-
Erasmus Medical CenterNot yet recruitingHIV Infections | Hiv | HIV-1-infection | HIV I InfectionNetherlands
-
University of WashingtonNational Institute of Mental Health (NIMH)RecruitingHIV Prevention | HIV Preexposure Prophylaxis | ImplementationKenya
-
University of Maryland, BaltimoreWithdrawnHiv | Kidney Transplant | HIV Reservoir | CCR5United States
Clinical Trials on "Smart" home-based test for HIV
-
Rhode Island HospitalCompleted
-
London School of Hygiene and Tropical MedicineUniversity College, London; World Health Organization; UNITAID; Liverpool School... and other collaboratorsCompleted
-
University of HaifaTechnion, Israel Institute of Technology; Hebrew University of JerusalemRecruiting
-
University of ZurichCompleted
-
Emory UniversityCenters for Disease Control and PreventionCompleted
-
Stanford UniversityPHawareCompletedPulmonary Arterial HypertensionUnited States
-
Samsung Medical CenterCompletedStrokeKorea, Republic of
-
University of ManitobaCompletedVestibular Neuronitis | Peripheral Vestibular Disorders | Vestibular Syndromes &/or Disorders (Labyrinthine)Canada
-
Public Health Service of AmsterdamZonMw: The Netherlands Organisation for Health Research and Development; Amsterdam... and other collaboratorsRecruitingHepatitis C Virus InfectionNetherlands, France
-
Montana State UniversityUniversity of Washington; Fred Hutchinson Cancer Center; National Institute of... and other collaboratorsCompleted